Coloma Jason V sold MAZE

May 15, 2026 · Form 4 insider transaction

Coloma Jason V sold 116 shares of Maze Therapeutics, Inc. at $26.00 per share, a transaction worth $3.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
116
Price
$26.00
Total value
$3.0K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 15, 2026
Filing dateMay 18, 2026
Shares owned after31,001
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

View the original Form 4 on SEC EDGAR